Endocrine-Related Cancer
Journal of Endocrinology (JOE)
Journal of Molecular Endocrinology (JME)
Endocrine-Related Cancer (ERC)
BioScientifica
Skip to main page content
HOME
ERC
About
Accepted MSS
New Articles
Free Reviews
Best Metabolism Booster
Best Testosterone Booster
Best Melatonin Supplement
RSS
Submit
HELP
Contact
Search for Keyword:
GO
Advanced Search
User Name
Password
Sign In
TERT
promoter mutations in thyroid cancer
Supplementary Table
Supplementary Table 1
- (PDF 48 KB)
This Article
Published online before print
January 5, 2016
, doi:
10.1530/ERC-15-0533
Endocr Relat Cancer
March 1, 2016
vol. 23
no. 3
R143-R155
Abstract
Free
Figures Only
Full Text
Full Text (PDF)
Supplementary Data
Supplementary Table
New Articles: issue in progress
March 2016, 23 (3)
Alert me to new issues of
Endocrine-Related Cancer
About BioScientifica journals
About SfE journals
About ESE journals
About this journal
Editorial board
For authors
Ethical guidelines
Bioscientifica Open Access policy
For readers
Most cited
/
most read
Recommend this journal to your library
Permissions information
Journal-based learning
For libraries
Sales and corporate services
Terms and conditions
Journals owned by the Society for Endocrinology
Journal of Endocrinology (JOE)
Journal of Molecular Endocrinology (JME)
Endocrine-Related Cancer (ERC)
Society for Endocrinology
European Society of Endocrinology
Most
Viewed
Association of Hashimoto's thyroiditis with thyroid cancer
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer
Bone metastases from differentiated thyroid carcinoma
Current and emerging biomarkers in breast cancer: prognosis and prediction
Prostate cancer: molecular biology of early progression to androgen independence
» View all Most Viewed articles
Cited
Fibroblast growth factors, their receptors and signaling
The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
BRAF mutation in thyroid cancer
mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition
» View all Most Cited articles